ACTIVE IMMUNIZATION OF HIV-1 INFECTED, PREGNANT WOMEN WITH CD4 LYMPHOCYTE COUNTS >= 400/MM3: A PHASE I STUDY OF SAFETY AND IMMUNOGENICITY OF VAXSYN RECOMBINANT GP160 (NOTE: SOME PATIENTS RECEIVE PLACEBO):